Middle East And Africa Hyaluronic Acid Market
Taille du marché en milliards USD
TCAC :
% 
 Période de prévision |
2023 –2030 |
 Taille du marché (année de référence) |
USD 263.81 Million |
 Taille du marché (année de prévision) |
USD 409.69 Million |
 TCAC |
% |
| Principaux acteurs du marché |
>Marché de l'acide hyaluronique au Moyen-Orient et en Afrique - Par qualité (qualité cosmétique et qualité pharmaceutique), type (acide hyaluronique hydrolysé, acide hyaluronique acétylé de sodium et hyaluronate de sodium), application (esthétique, arthrose, API pharmaceutique, cosmétiques , ophtalmologie et autres), utilisateur final (spas médicaux et centres de beauté, cliniques de dermatologie et centres de chirurgie esthétique), canal de distribution (appels d'offres directs et ventes au détail) Tendances de l'industrie et prévisions jusqu'en 2030.
Analyse et perspectives du marché de l'acide hyaluronique au Moyen-Orient et en Afrique
L'acide hyaluronique est principalement utilisé dans les produits de beauté et de soins de la peau. Il permet une guérison rapide des plaies, réduit les rides et le vieillissement de la peau, et guérit les coupures et les brûlures, entre autres. Il contient de la vitamine C pour éclaircir le teint. Les produits de beauté contenant de l'acide hyaluronique nourrissent la peau lorsqu'ils sont appliqués sous forme d'hydratants, de crèmes, de toniques pour la peau et de sérums, entre autres.
Data Bridge Market Research analyse que le marché de l'acide hyaluronique au Moyen-Orient et en Afrique croît avec un TCAC de 5,7 % au cours de la période de prévision de 2023 à 2030 et devrait atteindre 409,69 millions USD d'ici 2030 contre 263,81 millions USD en 2022.
|
Rapport métrique |
Détails |
|
Période de prévision |
2023 à 2030 |
|
Année de base |
2022 |
|
Années historiques |
2021 (personnalisable pour 2020-2016) |
|
Unités quantitatives |
Chiffre d'affaires en millions USD |
|
Segments couverts |
Par catégorie (qualité cosmétique et qualité pharmaceutique), type (acide hyaluronique hydrolysé, acide hyaluronique acétylé de sodium et hyaluronate de sodium), application (esthétique, arthrose, API pharmaceutique, cosmétiques, ophtalmologie et autres), utilisateur final (spas médicaux et centres de beauté, cliniques de dermatologie et centres de chirurgie esthétique), canal de distribution (appel d'offres direct et vente au détail). |
|
Pays couverts |
Afrique du Sud, Arabie saoudite, Émirats arabes unis, Égypte, Israël et reste du Moyen-Orient et de l’Afrique. |
|
Acteurs du marché couverts |
Fidia Farmaceutici SpA, AbbVie., Bloomage Biotechnology Co., Ltd., GALDERMA, LG Chem, Anika Therapeutics, Inc., Abbott, VIRCHOW BIOTECH, Kewpie Corporation, Merz North America, Inc., LABORATOIRES FILLMED, Prollenium Medical Technologies., Huons, Contipro as, Lifecore Biomedical, Inc., BioScience GmbH, Teoxane, Bioxis Pharmaceuticals, SHANDONG TOPSCIENCE BIOTECH CO., LTD., Bohus BioTech AB, RIVER PHARMA srl, Symatese, Stanford Chemicals détenue par Oceania International LLC, Bioiberica SAU, GENESIS pharmacy services et Brickell Men's Products, entre autres |
Définition du marché
Hyaluronic Acid (HA) also called hyaluronan, is an anionic, non-sulfated glycosaminoglycan distributed widely throughout connective, epithelial, and neural tissues. An essential component of articular cartilage, hyaluronic acid surrounds each cell in the cartilage like a coat (chondrocyte). The robustness of cartilage is due to these aggregates' ingestion of water (its resistance to compression). The molecular weight (size) of hyaluronan in cartilage decreases with age, but the amount increases. The human body naturally contains HA. The largest quantities of HA are seen in the joints and eyes. The chemical has the capacity to maintain luscious, moisturized skin. As a result, it is used by many cosmetic surgeons as an injectable to delay the signs of aging on the skin.
The increasing prevalence of minimally invasive procedures and rising awareness and demand for hyaluronic acid in pharmaceutical and cosmetic products across the globe are major driving factors for market growth in the forecast period. The dramatic rise in the quality of research coupled with increasing research opportunities is because of various strategic initiatives taken by the market players. They are taking initiatives such as product launches, collaborations, mergers, acquisitions, and many more over the years and are expected to lead and create more opportunities in the market.
Middle East and Africa Hyaluronic Acid Market Dynamics
This section deals with understanding the market drivers, advantages, opportunities, restraints, and challenges. All of this is discussed in detail below:
DRIVERS
- Increasing Awareness Towards Cosmetic Injectables or Dermal Fillers
Hyaluronic acid-based dermal fillers are the less invasive cosmetic processes. Dermatology problems are common across the globe. It has become a major concern to understand the products to treat skin-related problems and restore skin wrinkles. Various programs have been launched to create awareness about the proper use of hyaluronic acid injectables.
The increased consciousness will enable the consumers to opt for the correct treatment of acne and wrinkles and to select the right product (Botox injection, dermal fillers) as per the correct cause. This will lead to a rise in sales, a rise in the product portfolio, and an expansion of the product line. This factor is expected to propel the market growth.
- Use of Invasive Hyaluronic Acid Based Dermal Fillers
Hyaluronic acid-based dermal fillers are less invasive cosmetic processes, which are promptly increasing across the globe. These are popular cosmetic procedures for facial renovation, face volume restoration, and aesthetic improvement.
They are quite versatile and they are used on fine lines and wrinkles. In addition, these are also used for treating acne, wrinkles, and scars and for lip, cheek, and chin augmentation. The rise in the geriatric population has uplifted the necessity of non-invasive surgical protocols.
The implementation of hyaluronic acid-based dermal fillers will reduce the chances to opt for normal surgery. There is a minimum cost of treatment and this factor will boost the market growth.
RESTRAINTS
- Availability of Unauthorized or Alternative Dermal Fillers to Hamper Market
With the widespread accessibility of the aesthetic application of Hyaluronic acid-based dermal fillers, several limiting factors of these products are projected to hamper the Middle East and Africa market growth in the coming years.
Due to the high efficacy rate, patient satisfaction, and usage in dynamic wrinkles, botulinum toxin type, a dermal filler, is leading the non-surgical cosmetic procedure worldwide.
Furthermore, other biodegradable fillers, such as Calcium Hydroxyapatite (CaHA) and Poly-L-Latic acid are gaining popularity as alternative fillers used as implants with high longevity.
The reluctance among physicians has been observed to use low-cost illegal products, due to the risks involved in it. Conversely, the illegal products being available in the dermal filler segment will increase the competition in price, especially in the hyaluronic acid segment. Larger companies that provide high prices per unit have the ability to compete by offering multiple product bundles and selling products among various product divisions.
To compensate for fewer prices in hyaluronic acid dermal fillers, the particle and polymer manufacturers will have to promote the products. The products available in the segment vary. The manufacturers will focus more on the material strength used in dermal fillers, rather than on the cost price.
OPPORTUNITIES
- New Technology and Developments in Hyaluronic Acid Products
Advanced innovative technologies have improved aesthetic treatment for skin and other body parts wherever necessary and the skincare industry is one of the most rapidly changing ones. Homegrown brands with actives, ingredient-based skincare, and the beauty space are witnessing the rise of investment, and the consumer is keenly involved. The advanced innovative technology and developments of hyaluronic acid-based products boost the demand for hyaluronic acid in the market.
Hyaluronic dermal products are based on hyaluronic acid that corrects facial imperfections, compensates for volume, and emphasizes certain areas of the face. Advancement in dermal products offers an effective way to enhance, restore, and define facial features. Advancement in hyaluronic acid-based products and procedure of dermal fillers attracts customers toward cosmetics. Thus, it signifies that technological advancement in hyaluronic dermal products is expected to act as an opportunity for market growth.
CHALLENGES
- Escalating Product Recall
The recall of Hyaluronic acid-based products has greatly impacted the market growth. Regulatory authorities recall aesthetic and cosmetic products due to health and safety issues. Every country has its own regulatory authority which is responsible for monitoring the regulation of healthcare-related products.
Product recall by the companies or by the regulatory authorities for patient health safety concerns such as the inaccuracy of content or ingredient error are a few of the major concerns that act as a challenge to market growth as the patient’s safety and health are the most important criteria for any market introducing their products in the market.
Recent Developments
- In February 2022, Allergan (a subsidiary of AbbVie Inc.) announced the FDA approval of JUVÉDERM VOLBELLA XC for the improvement of infraorbital hollows in adults aged above 21. This helped the company to expand its product portfolio of aesthetics in the U.S. market.
- In February 2021, Contipro, a renowned hyaluronic acid manufacturer based in the Czech Republic, announced the launch of its new anti-aging and anti-acne treatment product called HyRetin, which improves the visibility of the skin.
Middle East and Africa Hyaluronic Acid Market Scope
Middle East and Africa hyaluronic acid market is segmented into five notable segments based on grade, type, application, end user, and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to make strategic decisions to identify core market applications.
Grade
- Cosmetic Grade
- Pharmaceutical Grade
Based on grade, the market is segmented into cosmetic grade and pharmaceutical grade.
Type
- Hydrolyzed Hyaluronic Acid
- Sodium Acetylated Hyaluronic Acid
- Sodium Hyaluronate
Based on type, the market is segmented into hydrolyzed hyaluronic acid, sodium acetylated hyaluronic acid, and sodium hyaluronate.
Application
- Aesthetics
- Osteoarthritis
- Pharmaceutical API
- Cosmetics
- Ophthalmology
- Others
Based on application, the market is segmented into aesthetics, osteoarthritis, pharmaceutical API, cosmetics, ophthalmology, and others.
End User
- Pharmaceutical Industry
- Dermatology Clinics
- Cosmetic Surgery Centers
- Others
Based on end user, the market is segmented into pharmaceutical industry, dermatology clinics, cosmetic surgery centers, and others.
Distribution Channel
- Direct Tender
- Retail Sales
Based on distribution channel, the market is segmented into direct tender and retail sales.
Middle East and Africa Hyaluronic Acid Market Regional Analysis/Insights
The Middle East and Africa hyaluronic acid market is analyzed, and market size insights and trends are provided by country, grade, type, application, end user, and distribution channel as referenced above.
The countries covered in this market report are South Africa, Saudi Arabia, UAE, Egypt, Israel, and rest of Middle East and Africa.
- En 2023, l'Afrique du Sud domine le marché de l'acide hyaluronique au Moyen-Orient et en Afrique en termes de part de marché et de chiffre d'affaires et continuera à accroître sa domination au cours de la période de prévision. Cela est dû à une augmentation des approbations de produits.
La section pays du rapport fournit également des facteurs d'impact sur les marchés individuels et des changements de réglementation sur le marché qui ont un impact sur les tendances actuelles et futures du marché. Les points de données, tels que les ventes de produits neufs et de remplacement, la démographie des pays, l'épidémiologie des maladies et les tarifs d'importation et d'exportation, sont quelques-uns des principaux indicateurs utilisés pour prévoir le scénario de marché pour les différents pays. En outre, la présence et la disponibilité des marques du Moyen-Orient et d'Afrique et les défis auxquels elles sont confrontées en raison de la concurrence des marques locales et nationales et l'impact des canaux de vente sont pris en compte tout en fournissant une analyse prévisionnelle des données nationales.
Analyse du paysage concurrentiel et des parts de marché de l'acide hyaluronique au Moyen-Orient et en Afrique
Le paysage concurrentiel du marché de l'acide hyaluronique au Moyen-Orient et en Afrique fournit des détails par concurrent. Les détails inclus sont la présentation de l'entreprise, les finances de l'entreprise, les revenus générés, le potentiel du marché, les investissements dans la recherche et le développement, les nouvelles initiatives du marché, la présence au Moyen-Orient et en Afrique, les sites et installations de production, les capacités de production, les forces et les faiblesses de l'entreprise, le lancement du produit, la largeur et l'étendue du produit et la domination des applications. Les points de données ci-dessus fournis ne concernent que l'orientation des entreprises par rapport au marché.
Français Certains des principaux acteurs opérant sur le marché de l'acide hyaluronique au Moyen-Orient et en Afrique sont Fidia Farmaceutici SpA, AbbVie., Bloomage Biotechnology Co., Ltd., GALDERMA, LG Chem, Anika Therapeutics, Inc., Abbott, VIRCHOW BIOTECH, Kewpie Corporation, Merz North America, Inc., LABORATOIRES FILLMED, Prollenium Medical Technologies., Huons, Contipro as, Lifecore Biomedical, Inc., BioScience GmbH, Teoxane, Bioxis Pharmaceuticals, SHANDONG TOPSCIENCE BIOTECH CO., LTD., Bohus BioTech AB, RIVER PHARMA srl, Symatese, Stanford Chemicals détenue par Oceania International LLC, Bioiberica SAU, GENESIS pharmacy services et Brickell Men's Products, entre autres.
SKU-
Accédez en ligne au rapport sur le premier cloud mondial de veille économique
- Tableau de bord d'analyse de données interactif
- Tableau de bord d'analyse d'entreprise pour les opportunités à fort potentiel de croissance
- Accès d'analyste de recherche pour la personnalisation et les requêtes
- Analyse de la concurrence avec tableau de bord interactif
- Dernières actualités, mises à jour et analyse des tendances
- Exploitez la puissance de l'analyse comparative pour un suivi complet de la concurrence
Table des matières
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE MIDDLE EAST & AFRICA HYALURONIC ACID MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 GRADE SEGMENT LIFELINE CURVE
2.8 DBMR MARKET POSITION GRID
2.9 VENDOR SHARE ANALYSIS
2.1 MARKET END USER COVERAGE GRID
2.11 SECONDARY SOURCES
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL ANALYSIS
4.2 PORTER'S FIVE FORCES
4.3 NUMBER OF AESTHETIC SURGERY PROCEDURES
4.4 INDUSTRY INSIGHTS
5 REGULATORY FRAMEWORK
5.1 EGULATORY SCENARIO IN THE U.S.
5.2 REGULATORY SCENARIO IN EUROPE
5.3 REGULATORY SCENARIO IN CHINA
5.4 REGULATORY SCENARIO IN AUSTRALIA
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 INCREASING AWARENESS TOWARDS COSMETIC INJECTABLES OR DERMAL FILLERS
6.1.2 USE OF INVASIVE HYALURONIC ACID BASED DERMAL FILLERS
6.1.3 RISE IN PRODUCT APPROVALS
6.1.4 GROWING POPULARITY OF NON-SURGICAL OR MINIMALLY INVASIVE COSMETIC PROCEDURES
6.2 RESTRAINTS
6.2.1 AVAILABILITY OF UNAUTHORIZED OR ALTERNATIVE DERMAL FILLERS TO HAMPER MARKET
6.2.2 POOR MEDICAL REIMBURSEMENT POLICIES
6.2.3 SIDE EFFECTS RELATED TO HYALURONIC ACID INJECTION
6.3 OPPORTUNITIES
6.3.1 NEW TECHNOLOGY AND DEVELOPMENTS IN HYALURONIC ACID PRODUCTS
6.3.2 NUTRICOSMETICS HYALURONIC ACID DERMAL FILLERS
6.3.3 STRATEGIC INITIATIVES BY MARKET PLAYERS
6.3.4 INCREASING RESEARCH AND DEVELOPMENT
6.4 CHALLENGES
6.4.1 ESCALATING PRODUCT RECALL
6.4.2 LACK OF EXPERTISE
7 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET, BY GRADE
7.1 OVERVIEW
7.2 COSMETIC GRADE
7.2.1 GENDER
7.2.1.1 FEMALE PRODUCTS
7.2.1.2 MEN’S PRODUCT
7.2.2 PRODUCT TYPE
7.2.2.1 SKIN CARE
7.2.2.2 MAKEUP
7.2.2.3 CLEANSING
7.2.2.4 HAIR CARE
7.2.2.5 OTHERS
7.2.3 PROCEDURE
7.2.3.1 WRINKLE REMOVAL
7.2.3.2 SKIN SMOOTHENING
7.2.3.3 FACE LIFT
7.2.3.4 LIP AUGMENTATION
7.2.3.5 CHIN AUGMENTATION
7.2.3.6 FAT INJECTION
7.2.3.7 FACE LINE CORRECTION
7.2.3.8 ACNE SCAR TREATMENT
7.2.3.9 LIP PLUM
7.2.3.10 EAR LOBE REJUVENATION
7.2.3.11 LIPOATROPHY TREATMENT
7.2.3.12 OTHERS
7.3 PHARMACEUTICAL GRADE
7.3.1 TYPE
7.3.1.1 MEDICAL GRADE HYALURONIC ACID
7.3.1.2 INJECTION GRADE HYALURONIC ACID
7.3.2 PRODUCT TYPE
7.3.2.1 TOPICAL PREPARATIONS
7.3.2.2 INTRA-ARTICULAR INJECTION
7.3.2.2.1 PREFILLED INJECTIONS
7.3.2.2.2 VIAL
7.3.2.3 EYE DROPS
7.3.2.4 ORAL PHARMACEUTICAL PREPARATIONS
7.3.2.5 OTHERS
8 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET, BY TYPE
8.1 OVERVIEW
8.2 SODIUM HYALURONATE
8.2.1 MOLECULAR WEIGHT
8.2.1.1 HIGH MOLECULAR WEIGHT
8.2.1.2 LOW MOLECULAR WEIGHT
8.2.1.3 MEDIUM MOLECULAR WEIGHT
8.2.2 BY TYPE
8.2.2.1 COSMETIC GRADE
8.2.2.1.1 GENDER
8.2.2.1.1.1 FEMALE PRODUCTS
8.2.2.1.1.2 MEN'S PRODUCT
8.2.2.1.2 PRODUCT TYPE
8.2.2.1.2.1 SKIN CARE
8.2.2.1.2.2 MAKEUP
8.2.2.1.2.3 CLEANSING
8.2.2.1.2.4 HAIR CARE
8.2.2.1.2.5 OTHERS
8.2.2.2 PHARMACEUTICAL GRADE
8.2.2.2.1 TYPE
8.2.2.2.1.1 MEDICAL GRADE HYALURONIC ACID
8.2.2.2.1.2 INJECTION GRADE HYALURONIC ACID
8.2.2.2.2 PRODUCT TYPE
8.2.2.2.2.1 TOPICAL PREPARATIONS
8.2.2.2.2.2 INTRA-ARTICULAR INJECTION
8.2.2.2.2.2.1 PREFILLED INJECTIONS
8.2.2.2.2.2.2 VIAL
8.2.2.2.2.3 EYE DROPS
8.2.2.2.2.4 ORAL PHARMACEUTICAL PREPARATIONS
8.2.2.2.2.5 OTHERS
8.3 HYDROLYZED HYALURONIC ACID
8.3.1 MOLECULAR WEIGHT
8.3.1.1 HIGH MOLECULAR WEIGHT
8.3.1.2 LOW MOLECULAR WEIGHT
8.3.1.3 MEDIUM MOLECULAR WEIGHT
8.3.2 BY TYPE
8.3.2.1 COSMETIC GRADE
8.3.2.1.1 GENDER
8.3.2.1.1.1 FEMALE PRODUCTS
8.3.2.1.1.2 MEN'S PRODUCT
8.3.2.1.2 PRODUCT TYPE
8.3.2.1.2.1 SKIN CARE
8.3.2.1.2.2 MAKEUP
8.3.2.1.2.3 CLEANSING
8.3.2.1.2.4 HAIR CARE
8.3.2.1.2.5 OTHERS
8.3.2.2 PHARMACEUTICAL GRADE
8.3.2.2.1 TYPE
8.3.2.2.1.1 MEDICAL GRADE HYALURONIC ACID
8.3.2.2.1.2 INJECTION GRADE HYALURONIC ACID
8.3.2.2.2 PRODUCT TYPE
8.3.2.2.2.1 TOPICAL PREPARATIONS
8.3.2.2.2.2 INTRA-ARTICULAR INJECTION
8.3.2.2.2.2.1 PREFILLED INJECTIONS
8.3.2.2.2.2.2 VIAL
8.3.2.2.2.3 EYE DROPS
8.3.2.2.2.4 ORAL PHARMACEUTICAL PREPARATIONS
8.3.2.2.2.5 OTHERS
8.4 SODIUM ACETYLATED HYALURONIC ACID
8.4.1 MOLECULAR WEIGHT
8.4.1.1 HIGH MOLECULAR WEIGHT
8.4.1.2 LOW MOLECULAR WEIGHT
8.4.1.3 MEDIUM MOLECULAR WEIGHT
8.4.2 BY TYPE
8.4.2.1 COSMETIC GRADE
8.4.2.1.1 GENDER
8.4.2.1.1.1 FEMALE PRODUCTS
8.4.2.1.1.2 MEN'S PRODUCT
8.4.2.1.2 PRODUCT TYPE
8.4.2.1.2.1 SKIN CARE
8.4.2.1.2.2 MAKEUP
8.4.2.1.2.3 CLEANSING
8.4.2.1.2.4 HAIR CARE
8.4.2.1.2.5 OTHERS
8.4.2.2 PHARMACEUTICAL GRADE
8.4.2.2.1 TYPE
8.4.2.2.1.1 MEDICAL GRADE HYALURONIC ACID
8.4.2.2.1.2 INJECTION GRADE HYALURONIC ACID
8.4.2.2.2 PRODUCT TYPE
8.4.2.2.2.1 TOPICAL PREPARATIONS
8.4.2.2.2.2 INTRA-ARTICULAR INJECTION
8.4.2.2.2.2.1 PREFILLED INJECTIONS
8.4.2.2.2.2.2 VIAL
8.4.2.2.2.3 EYE DROPS
8.4.2.2.2.4 ORAL PHARMACEUTICAL PREPARATIONS
8.4.2.2.2.5 OTHERS
9 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET, BY APPLICATION
9.1 OVERVIEW
9.2 AESTHETICS
9.3 OSTEOARTHRITIS
9.4 COSMETICS
9.5 OPHTHALMOLOGY
9.6 PHARMACEUTICAL API
9.7 OTHERS
10 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET, BY END USER
10.1 OVERVIEW
10.2 DERMATOLOGY CLINICS
10.3 COSMETIC SURGERY CENTERS
10.4 MEDICAL SPAS AND BEAUTY CENTERS
10.5 OTHERS
11 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL
11.1 OVERVIEW
11.2 RETAIL SALES
11.2.1 RETAIL PHARMACY
11.2.2 HOSPITAL PHARMACY
11.2.3 ONLINE PHARMACY
11.3 DIRECT TENDER
12 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET, BY REGION
12.1 MIDDLE EAST AND AFRICA
12.1.1 SOUTH AFRICA
12.1.2 SAUDI ARABIA
12.1.3 U.A.E.
12.1.4 EGYPT
12.1.5 ISRAEL
12.1.6 REST OF MIDDLE EAST AND AFRICA
13 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: COMPANY LANDSCAPE
13.1 COMPANY SHARE ANALYSIS: MIDDLE EAST & AFRICA
14 SWOT ANALYSIS
15 COMPANY PROFILE
15.1 FIDIA FARMACEUTICI S.P.A. (2022)
15.1.1 COMPANY SNAPSHOT
15.1.2 REVENUE ANALYSIS
15.1.3 COMPANY SHARE ANALYSIS
15.1.4 PRODUCT PORTFOLIO
15.1.5 RECENT DEVELOPMENT
15.2 ABBVIE INC.
15.2.1 COMPANY SNAPSHOT
15.2.2 REVENUE ANALYSIS
15.2.3 COMPANY SHARE ANALYSIS
15.2.4 PRODUCT PORTFOLIO
15.2.5 RECENT DEVELOPMENTS
15.3 BLOOMAGE BIOTECHNOLOGY CORPORATION LIMITED
15.3.1 COMPANY SNAPSHOT
15.3.2 COMPANY SHARE ANALYSIS
15.3.3 PRODUCT PORTFOLIO
15.3.4 RECENT DEVELOPMENTS
15.4 GALDERMA
15.4.1 COMPANY SNAPSHOT
15.4.2 COMPANY SHARE ANALYSIS
15.4.3 PRODUCT PORTFOLIO
15.4.4 RECENT DEVELOPMENTS
15.5 LG CHEM (2022)
15.5.1 COMPANY SNAPSHOT
15.5.2 REVENUE ANALYSIS
15.5.3 COMPANY SHARE ANALYSIS
15.5.4 PRODUCT PORTFOLIO
15.5.5 RECENT DEVELOPMENTS
15.6 ABBOTT (2022)
15.6.1 COMPANY SNAPSHOT
15.6.2 REVENUE ANALYSIS
15.6.3 PRODUCT PORTFOLIO
15.6.4 RECENT DEVELOPMENTS
15.7 ANIKA THERAPEUTICS, INC.
15.7.1 COMPANY SNAPSHOT
15.7.2 REVENUE ANALYSIS
15.7.3 COMPANY SHARE ANALYSIS
15.7.4 PRODUCT PORTFOLIO
15.7.5 RECENT DEVELOPMENTS
15.8 BIOSCIENCE GMBH
15.8.1 COMPANY SNAPSHOT
15.8.2 PRODUCT PORTFOLIO
15.8.3 RECENT DEVELOPMENT
15.9 BIOXIS PHARMACEUTICALS
15.9.1 COMPANY SNAPSHOT
15.9.2 PRODUCT PORTFOLIO
15.9.3 RECENT DEVELOPMENTS
15.1 BIOIBERICA S.A.U
15.10.1 COMPANY SNAPSHOT
15.10.2 PRODUCT PORTFOLIO
15.10.3 RECENT DEVELOPMENTS
15.11 BOHUS BIOTECH AB
15.11.1 COMPANY SNAPSHOT
15.11.2 PRODUCT PORTFOLIO
15.11.3 RECENT DEVELOPMENTS
15.12 BRICKELL MEN'S PRODUCTS
15.12.1 COMPANY SNAPSHOT
15.12.2 PRODUCT PORTFOLIO
15.12.3 RECENT DEVELOPMENT
15.13 CONTIPRO A.S.
15.13.1 COMPANY SNAPSHOT
15.13.2 PRODUCT PORTFOLIO
15.13.3 RECENT DEVELOPMENTS
15.14 FILLMED
15.14.1 COMPANY SNAPSHOT
15.14.2 PRODUCT PORTFOLIO
15.14.3 RECENT DEVELOPMENT
15.15 GENESIS
15.15.1 COMPANY SNAPSHOT
15.15.2 PRODUCT PORTFOLIO
15.15.3 RECENT DEVELOPMENT
15.16 HUONS
15.16.1 COMPANY SNAPSHOT
15.16.2 PRODUCT PORTFOLIO
15.16.3 RECENT DEVELOPMENTS
15.17 KEWPIE CORPORATION
15.17.1 COMPANY SNAPSHOT
15.17.2 PRODUCT PORTFOLIO
15.17.3 RECENT DEVELOPMENTS
15.18 LIFECORE BIOMEDICAL, INC.(2022)
15.18.1 COMPANY SNAPSHOT
15.18.2 REVENUE ANALYSIS
15.18.3 PRODUCT PORTFOLIO
15.18.4 RECENT DEVELOPMENTS
15.19 MERZ NORTH AMERICA, INC. (A SUBSIDIARY OF MERZ PHARMA)
15.19.1 COMPANY SNAPSHOT
15.19.2 PRODUCT PORTFOLIO
15.19.3 RECENT DEVELOPMENTS
15.2 PROLLENIUM MEDICAL TECHNOLOGIES
15.20.1 COMPANY SNAPSHOT
15.20.2 PRODUCT PORTFOLIO
15.20.3 RECENT DEVELOPMENTS
15.21 RIVER PHARMA S.R.L.
15.21.1 COMPANY SNAPSHOT
15.21.2 PRODUCT PORTFOLIO
15.21.3 RECENT DEVELOPMENT
15.22 SHANDONG TOPSCIENCE BIOTECH CO., LTD.
15.22.1 COMPANY SNAPSHOT
15.22.2 PRODUCT PORTFOLIO
15.22.3 RECENT DEVELOPMENTS
15.23 STANFORD CHEMICALS OWNED BY OCEANIA INTERNATIONAL LLC,
15.23.1 COMPANY SNAPSHOT
15.23.2 PRODUCT PORTFOLIO
15.23.3 RECENT DEVELOPMENTS
15.24 SYMATESE
15.24.1 COMPANY SNAPSHOT
15.24.2 PRODUCT PORTFOLIO
15.24.3 RECENT DEVELOPMENTS
15.25 TEOXANE
15.25.1 COMPANY SNAPSHOT
15.25.2 PRODUCT PORTFOLIO
15.25.3 RECENT DEVELOPMENTS
15.26 VIRCHOW BIOTECH
15.26.1 COMPANY SNAPSHOT
15.26.2 PRODUCT PORTFOLIO
15.26.3 RECENT DEVELOPMENTS
16 QUESTIONNAIRE
17 RELATED REPORTS
Liste des tableaux
TABLE 1 U.S. AESTHETIC PLASTIC SURGERY PROCEDURES COUNT IN 2021 AND 2020:
TABLE 2 REQUIRED TIME, NUMBER OF TREATMENTS, REST TIME
TABLE 3 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET, BY GRADE, 2021-2030 (USD MILLION)
TABLE 4 MIDDLE EAST & AFRICA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 5 MIDDLE EAST & AFRICA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 6 MIDDLE EAST & AFRICA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 7 MIDDLE EAST & AFRICA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PROCEDURE, 2021-2030 (USD MILLION)
TABLE 8 MIDDLE EAST & AFRICA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 9 MIDDLE EAST & AFRICA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 10 MIDDLE EAST & AFRICA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 11 MIDDLE EAST & AFRICA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 12 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 13 MIDDLE EAST & AFRICA SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 14 MIDDLE EAST & AFRICA SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)
TABLE 15 MIDDLE EAST & AFRICA SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 16 MIDDLE EAST & AFRICA COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 17 MIDDLE EAST & AFRICA COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 18 MIDDLE EAST & AFRICA PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 19 MIDDLE EAST & AFRICA PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 20 MIDDLE EAST & AFRICA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 21 MIDDLE EAST & AFRICA HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 22 MIDDLE EAST & AFRICA HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)
TABLE 23 MIDDLE EAST & AFRICA HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 24 MIDDLE EAST & AFRICA COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 25 MIDDLE EAST & AFRICA COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 26 MIDDLE EAST & AFRICA PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 27 MIDDLE EAST & AFRICA PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 28 MIDDLE EAST & AFRICA INTRA-ARTICULAR INJECTION IN PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 29 MIDDLE EAST & AFRICA SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 30 MIDDLE EAST & AFRICA SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)
TABLE 31 MIDDLE EAST & AFRICA SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 32 MIDDLE EAST & AFRICA COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 33 MIDDLE EAST & AFRICA COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 34 MIDDLE EAST & AFRICA PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 35 MIDDLE EAST & AFRICA PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 36 MIDDLE EAST & AFRICA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 37 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 38 MIDDLE EAST & AFRICA AESTHETICS IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 39 MIDDLE EAST & AFRICA OSTEOARTHRITIS IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 40 MIDDLE EAST & AFRICA COSMETICS IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 41 MIDDLE EAST & AFRICA OPHTHALMOLOGY IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 42 MIDDLE EAST & AFRICA PHARMACEUTICAL API IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 43 MIDDLE EAST & AFRICA OTHERS IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 44 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 45 MIDDLE EAST & AFRICA DERMATOLOGY CLINICS IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 46 MIDDLE EAST & AFRICA COSMETIC SURGERY CENTERS IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 47 MIDDLE EAST & AFRICA MEDICAL SPAS AND BEAUTY CENTERS IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 48 MIDDLE EAST & AFRICA OTHERS IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 49 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 50 MIDDLE EAST & AFRICA RETAIL SALES IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 51 MIDDLE EAST & AFRICA RETAIL SALES IN HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 52 MIDDLE EAST & AFRICA DIRECT TENDER IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 53 MIDDLE EAST AND AFRICA HYALURONIC ACID MARKET, BY COUNTRY, 2021-2030 (USD MILLION)
TABLE 54 MIDDLE EAST AND AFRICA HYALURONIC ACID MARKET, BY GRADE, 2021-2030 (USD MILLION)
TABLE 55 MIDDLE EAST AND AFRICA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 56 MIDDLE EAST AND AFRICA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 57 MIDDLE EAST AND AFRICA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)
TABLE 58 MIDDLE EAST AND AFRICA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 59 MIDDLE EAST AND AFRICA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PROCEDURE, 2021-2030 (USD MILLION)
TABLE 60 MIDDLE EAST AND AFRICA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 61 MIDDLE EAST AND AFRICA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (VOLUME IN MILLION UNITS)
TABLE 62 MIDDLE EAST AND AFRICA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (ASP IN USD)
TABLE 63 MIDDLE EAST AND AFRICA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 64 MIDDLE EAST AND AFRICA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)
TABLE 65 MIDDLE EAST AND AFRICA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 66 MIDDLE EAST AND AFRICA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 67 MIDDLE EAST AND AFRICA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)
TABLE 68 MIDDLE EAST AND AFRICA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 69 MIDDLE EAST AND AFRICA HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 70 MIDDLE EAST AND AFRICA SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)
TABLE 71 MIDDLE EAST AND AFRICA SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 72 MIDDLE EAST AND AFRICA COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 73 MIDDLE EAST AND AFRICA COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 74 MIDDLE EAST AND AFRICA PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 75 MIDDLE EAST AND AFRICA PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 76 MIDDLE EAST AND AFRICA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 77 MIDDLE EAST AND AFRICA HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)
TABLE 78 MIDDLE EAST AND AFRICA HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 79 MIDDLE EAST AND AFRICA COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 80 MIDDLE EAST AND AFRICA COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 81 MIDDLE EAST AND AFRICA PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 82 MIDDLE EAST AND AFRICA PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 83 MIDDLE EAST AND AFRICA INTRA-ARTICULAR INJECTION IN PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 84 MIDDLE EAST AND AFRICA SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)
TABLE 85 MIDDLE EAST AND AFRICA SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 86 MIDDLE EAST AND AFRICA COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 87 MIDDLE EAST AND AFRICA COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 88 MIDDLE EAST AND AFRICA PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 89 MIDDLE EAST AND AFRICA PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 90 MIDDLE EAST AND AFRICA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 91 MIDDLE EAST AND AFRICA HYALURONIC ACID MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 92 MIDDLE EAST AND AFRICA HYALURONIC ACID MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 93 MIDDLE EAST AND AFRICA HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 94 MIDDLE EAST AND AFRICA RETAIL SALES IN HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 95 SOUTH AFRICA HYALURONIC ACID MARKET, BY GRADE, 2021-2030 (USD MILLION)
TABLE 96 SOUTH AFRICA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 97 SOUTH AFRICA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 98 SOUTH AFRICA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)
TABLE 99 SOUTH AFRICA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 100 SOUTH AFRICA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PROCEDURE, 2021-2030 (USD MILLION)
TABLE 101 SOUTH AFRICA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 102 SOUTH AFRICA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (VOLUME IN MILLION UNITS)
TABLE 103 SOUTH AFRICA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (ASP IN USD)
TABLE 104 SOUTH AFRICA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 105 SOUTH AFRICA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)
TABLE 106 SOUTH AFRICA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 107 SOUTH AFRICA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 108 SOUTH AFRICA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)
TABLE 109 SOUTH AFRICA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 110 SOUTH AFRICA HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 111 SOUTH AFRICA SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)
TABLE 112 SOUTH AFRICA SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 113 SOUTH AFRICA COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 114 SOUTH AFRICA COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 115 SOUTH AFRICA PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 116 SOUTH AFRICA PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 117 SOUTH AFRICA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 118 SOUTH AFRICA HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)
TABLE 119 SOUTH AFRICA HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 120 SOUTH AFRICA COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 121 SOUTH AFRICA COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 122 SOUTH AFRICA PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 123 SOUTH AFRICA PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 124 SOUTH AFRICA INTRA-ARTICULAR INJECTION IN PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 125 SOUTH AFRICA SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)
TABLE 126 SOUTH AFRICA SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 127 SOUTH AFRICA COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 128 SOUTH AFRICA COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 129 SOUTH AFRICA PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 130 SOUTH AFRICA PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 131 SOUTH AFRICA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 132 SOUTH AFRICA HYALURONIC ACID MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 133 SOUTH AFRICA HYALURONIC ACID MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 134 SOUTH AFRICA HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 135 SOUTH AFRICA RETAIL SALES IN HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 136 SAUDI ARABIA HYALURONIC ACID MARKET, BY GRADE, 2021-2030 (USD MILLION)
TABLE 137 SAUDI ARABIA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 138 SAUDI ARABIA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 139 SAUDI ARABIA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)
TABLE 140 SAUDI ARABIA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 141 SAUDI ARABIA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PROCEDURE, 2021-2030 (USD MILLION)
TABLE 142 SAUDI ARABIA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 143 SAUDI ARABIA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (VOLUME IN MILLION UNITS)
TABLE 144 SAUDI ARABIA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (ASP IN USD)
TABLE 145 SAUDI ARABIA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 146 SAUDI ARABIA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)
TABLE 147 SAUDI ARABIA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 148 SAUDI ARABIA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 149 SAUDI ARABIA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)
TABLE 150 SAUDI ARABIA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 151 SAUDI ARABIA HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 152 SAUDI ARABIA SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)
TABLE 153 SAUDI ARABIA SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 154 SAUDI ARABIA COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 155 SAUDI ARABIA COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 156 SAUDI ARABIA PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 157 SAUDI ARABIA PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 158 SAUDI ARABIA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 159 SAUDI ARABIA HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)
TABLE 160 SAUDI ARABIA HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 161 SAUDI ARABIA COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 162 SAUDI ARABIA COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 163 SAUDI ARABIA PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 164 SAUDI ARABIA PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 165 SAUDI ARABIA INTRA-ARTICULAR INJECTION IN PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 166 SAUDI ARABIA SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)
TABLE 167 SAUDI ARABIA SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 168 SAUDI ARABIA COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 169 SAUDI ARABIA COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 170 SAUDI ARABIA PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 171 SAUDI ARABIA PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 172 SAUDI ARABIA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 173 SAUDI ARABIA HYALURONIC ACID MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 174 SAUDI ARABIA HYALURONIC ACID MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 175 SAUDI ARABIA HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 176 SAUDI ARABIA RETAIL SALES IN HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 177 U.A.E. HYALURONIC ACID MARKET, BY GRADE, 2021-2030 (USD MILLION)
TABLE 178 U.A.E. COSMETIC GRADE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 179 U.A.E. COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 180 U.A.E. COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)
TABLE 181 U.A.E. COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 182 U.A.E. COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PROCEDURE, 2021-2030 (USD MILLION)
TABLE 183 U.A.E. PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 184 U.A.E. PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (VOLUME IN MILLION UNITS)
TABLE 185 U.A.E. PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (ASP IN USD)
TABLE 186 U.A.E. PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 187 U.A.E. PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)
TABLE 188 U.A.E. PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 189 U.A.E. INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 190 U.A.E. INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)
TABLE 191 U.A.E. INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 192 U.A.E. HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 193 U.A.E. SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)
TABLE 194 U.A.E. SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 195 U.A.E. COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 196 U.A.E. COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 197 U.A.E. PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 198 U.A.E. PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 199 U.A.E. INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 200 U.A.E. HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)
TABLE 201 U.A.E. HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 202 U.A.E. COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 203 U.A.E. COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 204 U.A.E. PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 205 U.A.E. PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 206 U.A.E. INTRA-ARTICULAR INJECTION IN PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 207 U.A.E. SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)
TABLE 208 U.A.E. SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 209 U.A.E. COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 210 U.A.E. COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 211 U.A.E. PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 212 U.A.E. PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 213 U.A.E. INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 214 U.A.E. HYALURONIC ACID MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 215 U.A.E. HYALURONIC ACID MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 216 U.A.E. HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 217 U.A.E. RETAIL SALES IN HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 218 EGYPT HYALURONIC ACID MARKET, BY GRADE, 2021-2030 (USD MILLION)
TABLE 219 EGYPT COSMETIC GRADE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 220 EGYPT COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 221 EGYPT COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)
TABLE 222 EGYPT COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 223 EGYPT COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PROCEDURE, 2021-2030 (USD MILLION)
TABLE 224 EGYPT PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 225 EGYPT PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (VOLUME IN MILLION UNITS)
TABLE 226 EGYPT PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (ASP IN USD)
TABLE 227 EGYPT PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 228 EGYPT PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)
TABLE 229 EGYPT PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 230 EGYPT INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 231 EGYPT INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)
TABLE 232 EGYPT INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 233 EGYPT HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 234 EGYPT SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)
TABLE 235 EGYPT SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 236 EGYPT COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 237 EGYPT COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 238 EGYPT PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 239 EGYPT PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 240 EGYPT INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 241 EGYPT HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)
TABLE 242 EGYPT HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 243 EGYPT COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 244 EGYPT COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 245 EGYPT PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 246 EGYPT PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 247 EGYPT INTRA-ARTICULAR INJECTION IN PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 248 EGYPT SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)
TABLE 249 EGYPT SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 250 EGYPT COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 251 EGYPT COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 252 EGYPT PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 253 EGYPT PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 254 EGYPT INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 255 EGYPT HYALURONIC ACID MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 256 EGYPT HYALURONIC ACID MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 257 EGYPT HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 258 EGYPT RETAIL SALES IN HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 259 ISRAEL HYALURONIC ACID MARKET, BY GRADE, 2021-2030 (USD MILLION)
TABLE 260 ISRAEL COSMETIC GRADE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 261 ISRAEL COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 262 ISRAEL COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)
TABLE 263 ISRAEL COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 264 ISRAEL COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PROCEDURE, 2021-2030 (USD MILLION)
TABLE 265 ISRAEL PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 266 ISRAEL PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (VOLUME IN MILLION UNITS)
TABLE 267 ISRAEL PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (ASP IN USD)
TABLE 268 ISRAEL PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 269 ISRAEL PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)
TABLE 270 ISRAEL PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 271 ISRAEL INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 272 ISRAEL INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)
TABLE 273 ISRAEL INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 274 ISRAEL HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 275 ISRAEL SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)
TABLE 276 ISRAEL SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 277 ISRAEL COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 278 ISRAEL COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 279 ISRAEL PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 280 ISRAEL PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 281 ISRAEL INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 282 ISRAEL HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)
TABLE 283 ISRAEL HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 284 ISRAEL COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 285 ISRAEL COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 286 ISRAEL PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 287 ISRAEL PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 288 ISRAEL INTRA-ARTICULAR INJECTION IN PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 289 ISRAEL SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)
TABLE 290 ISRAEL SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 291 ISRAEL COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 292 ISRAEL COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 293 ISRAEL PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 294 ISRAEL PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 295 ISRAEL INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 296 ISRAEL HYALURONIC ACID MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 297 ISRAEL HYALURONIC ACID MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 298 ISRAEL HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 299 ISRAEL RETAIL SALES IN HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 300 REST OF MIDDLE EAST AND AFRICA HYALURONIC ACID MARKET, BY GRADE, 2021-2030 (USD MILLION)
Liste des figures
FIGURE 1 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: SEGMENTATION
FIGURE 2 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: DATA TRIANGULATION
FIGURE 3 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: DROC ANALYSIS
FIGURE 4 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: MIDDLE EAST & AFRICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: DBMR POSITION GRID
FIGURE 8 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: VENDOR SHARE ANALYSIS
FIGURE 9 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: END USER COVERAGE GRID
FIGURE 10 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: SEGMENTATION
FIGURE 11 RISING POPULARITY OF NON-SURGICAL OR MINIMALLY INVASIVE COSMETIC PROCEDURES IS EXPECTED TO DRIVE THE MIDDLE EAST & AFRICA HYALURONIC ACID MARKET FROM 2023 TO 2030
FIGURE 12 THE GRADE SEGMENT IS EXPECTED TO HAVE THE LARGEST SHARE OF THE MIDDLE EAST & AFRICA HYALURONIC ACID MARKET FROM 2023 TO 2030
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF MIDDLE EAST & AFRICA HYALURONIC ACID MARKET
FIGURE 14 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: BY GRADE, 2022
FIGURE 15 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: BY GRADE, 2023-2030 (USD MILLION)
FIGURE 16 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: BY GRADE, CAGR (2023-2030)
FIGURE 17 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: BY GRADE, LIFELINE CURVE
FIGURE 18 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: BY TYPE, 2022
FIGURE 19 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: BY TYPE, 2023-2030 (USD MILLION)
FIGURE 20 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: BY TYPE, CAGR (2023-2030)
FIGURE 21 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: BY TYPE, LIFELINE CURVE
FIGURE 22 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: BY APPLICATION, 2022
FIGURE 23 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: BY APPLICATION, 2023-2030 (USD MILLION)
FIGURE 24 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: BY APPLICATION, CAGR (2023-2030)
FIGURE 25 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 26 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: BY END USER, 2022
FIGURE 27 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: BY END USER, 2023-2030 (USD MILLION)
FIGURE 28 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: BY END USER, CAGR (2023-2030)
FIGURE 29 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: BY END USER, LIFELINE CURVE
FIGURE 30 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: BY DISTRIBUTION CHANNEL, 2022
FIGURE 31 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
FIGURE 32 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)
FIGURE 33 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 34 MIDDLE EAST AND AFRICA HYALURONIC ACID MARKET: SNAPSHOT (2022)
FIGURE 35 MIDDLE EAST AND AFRICA HYALURONIC ACID MARKET: BY COUNTRY (2022)
FIGURE 36 MIDDLE EAST AND AFRICA HYALURONIC ACID MARKET: BY COUNTRY (2023 & 2030)
FIGURE 37 MIDDLE EAST AND AFRICA HYALURONIC ACID MARKET: BY COUNTRY (2022 & 2030)
FIGURE 38 MIDDLE EAST AND AFRICA HYALURONIC ACID MARKET: GRADE (2023-2030)
FIGURE 39 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: COMPANY SHARE 2022 (%)
Méthodologie de recherche
La collecte de données et l'analyse de l'année de base sont effectuées à l'aide de modules de collecte de données avec des échantillons de grande taille. L'étape consiste à obtenir des informations sur le marché ou des données connexes via diverses sources et stratégies. Elle comprend l'examen et la planification à l'avance de toutes les données acquises dans le passé. Elle englobe également l'examen des incohérences d'informations observées dans différentes sources d'informations. Les données de marché sont analysées et estimées à l'aide de modèles statistiques et cohérents de marché. De plus, l'analyse des parts de marché et l'analyse des tendances clés sont les principaux facteurs de succès du rapport de marché. Pour en savoir plus, veuillez demander un appel d'analyste ou déposer votre demande.
La méthodologie de recherche clé utilisée par l'équipe de recherche DBMR est la triangulation des données qui implique l'exploration de données, l'analyse de l'impact des variables de données sur le marché et la validation primaire (expert du secteur). Les modèles de données incluent la grille de positionnement des fournisseurs, l'analyse de la chronologie du marché, l'aperçu et le guide du marché, la grille de positionnement des entreprises, l'analyse des brevets, l'analyse des prix, l'analyse des parts de marché des entreprises, les normes de mesure, l'analyse globale par rapport à l'analyse régionale et des parts des fournisseurs. Pour en savoir plus sur la méthodologie de recherche, envoyez une demande pour parler à nos experts du secteur.
Personnalisation disponible
Data Bridge Market Research est un leader de la recherche formative avancée. Nous sommes fiers de fournir à nos clients existants et nouveaux des données et des analyses qui correspondent à leurs objectifs. Le rapport peut être personnalisé pour inclure une analyse des tendances des prix des marques cibles, une compréhension du marché pour d'autres pays (demandez la liste des pays), des données sur les résultats des essais cliniques, une revue de la littérature, une analyse du marché des produits remis à neuf et de la base de produits. L'analyse du marché des concurrents cibles peut être analysée à partir d'une analyse basée sur la technologie jusqu'à des stratégies de portefeuille de marché. Nous pouvons ajouter autant de concurrents que vous le souhaitez, dans le format et le style de données que vous recherchez. Notre équipe d'analystes peut également vous fournir des données sous forme de fichiers Excel bruts, de tableaux croisés dynamiques (Fact book) ou peut vous aider à créer des présentations à partir des ensembles de données disponibles dans le rapport.
